Ownership history in Point72 (DIFC) Ltd · 13 quarters on record
This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in REGENERON PHARMACEUTICALS (REGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 5,840 | -2,558 | -30.5% | 0.22% | $3.3M | $560.89 |
| 2025 Q2 | ADDED | 8,398 | +4,798 | +133.3% | 0.17% | $4.4M | $522.92 |
| 2025 Q2 | REDUCED | 3,600 | -4,200 | -53.8% | 0.07% | $1.9M | $522.92 |
| 2025 Q2 | ADDED | 7,800 | +6,000 | +333.3% | 0.15% | $4.1M | $522.92 |
| 2025 Q1 | REDUCED | 1,800 | -100 | -5.3% | 0.05% | $1.1M | $630.78 |
| 2025 Q1 | REDUCED | 1,900 | -300 | -13.6% | 0.05% | $1.2M | $630.78 |
| 2024 Q4 | REDUCED | 2,200 | -3,628 | -62.3% | 0.06% | $1.6M | $707.55 |
| 2024 Q4 | ADDED | 5,828 | +4,828 | +482.8% | 0.15% | $4.2M | $707.55 |
| 2024 Q4 | ADDED | 1,000 | +200 | +25.0% | 0.03% | $712K | $707.55 |
| 2024 Q2 | ADDED | 800 | +300 | +60.0% | 0.03% | $841K | $1043.98 |
As of 2025 Q4 — sorted by position size